RT Journal Article
T1 The ERA-EDTA Registry Annual Report 2018: a summary.
A1 Kramer, Anneke
A1 Boenink, Rianne
A1 Stel, Vianda S
A1 Santiuste de Pablos, Carmen
A1 Tomović, Filip
A1 Golan, Eliezer
A1 Kerschbaum, Julia
A1 Seyahi, Nurhan
A1 Ioanou, Kyriakos
A1 Beltrán, Palma
A1 Zurriaga, Oscar
A1 Magaz, Ángela
A1 Slon Roblero, María F
A1 Gjorgjievski, Nikola
A1 Garneata, Liliana
A1 Arribas, Federico
A1 Galvão, Ana A
A1 Bell, Samira
A1 Ots-Rosenberg, Mai
A1 Muñoz-Terol, José M
A1 Winzeler, Rebecca
A1 Hommel, Kristine
A1 Åsberg, Anders
A1 Spustova, Viera
A1 Palencia García, María Ángeles
A1 Vazelov, Evgueniy
A1 Finne, Patrik
A1 Ten Dam, Marc A G J
A1 Lopot, František
A1 Trujillo-Alemán, Sara
A1 Lassalle, Mathilde
A1 Kolesnyk, Mykola O
A1 Santhakumaran, Shalini
A1 Idrizi, Alma
A1 Andrusev, Anton
A1 Comas Farnés, Jordi
A1 Komissarov, Kirill
A1 Resić, Halima
A1 Palsson, Runolfur
A1 Kuzema, Viktorija
A1 Garcia Bazaga, Maria Angeles
A1 Ziginskiene, Edita
A1 Stendahl, Maria
A1 Bonthuis, Marjolein
A1 Massy, Ziad A
A1 Jager, Kitty J
K1 dialysis
K1 epidemiology
K1 kidney failure
K1 kidney transplantation
K1 survival analysis
AB The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
SN 2048-8505
YR 2020
FD 2020-12-24
LK https://hdl.handle.net/10668/27277
UL https://hdl.handle.net/10668/27277
LA en
DS RISalud
RD Apr 4, 2025